Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review

Detalhes bibliográficos
Autor(a) principal: Alves, Melina Fonseca Maia França Coury
Data de Publicação: 2022
Outros Autores: Figueiredo, Bárbara Queiroz de, Coury, Bruno Faria, Freitas, Flávia Garcia, Ribeiro, Julia da Cunha, Oliveira, Júlia de Sousa, Costa, Júlia Silva Coimbra, Neiva, Juliana Silva, Oliveira, Rúbia Carla
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/26196
Resumo: Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist.
id UNIFEI_916b62f21995f9669bee9516d315741d
oai_identifier_str oai:ojs.pkp.sfu.ca:article/26196
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature reviewEvidencia sobre el uso de glucocorticoides como terapia para la sepsis: una revisión integrativa de la literaturaEvidências acerca do uso de glicocorticoides como terapêutica para sepse: uma revisão integrativa de literaturaGlucocorticoidesSepticemiaTerapia intensiva.GlucocorticoidsSepsisIntensive therapy.GlicocorticoidesSepseTerapia intensiva. Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist.Introducción: la sepsis es una enfermedad inflamatoria sistémica asociada a una infección con manifestaciones graves que se presenta en todo el organismo. Sin embargo, esta infección no necesariamente tiene que estar en todas partes del cuerpo, puede estar restringida a un solo lugar, pero causar una respuesta inflamatoria en todo el cuerpo para tratar de controlar la causa de la infección. Objetivo: demostrar la evidencia actual sobre el uso de corticoides en el tratamiento de la sepsis en pacientes hospitalizados en unidades de cuidados intensivos (UCI). Metodología: se trata de una investigación descriptiva del tipo revisión integrativa de la literatura. Se cruzaron los descriptores, en inglés: "sepsis", "hemodynamic", "corticosteroids", en portugués: "sepsis", "hemodynamics", "corticosteroids" y en español: "sepsis", "hemodynamic", "corticosteroids", en las siguientes bases de datos: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) y EBSCO Information Services. Resultados y discusión: el tratamiento puede realizarse con corticoides para atenuar y modificar la respuesta inflamatoria, además de ofrecer un costo accesible. Sin embargo, algunos efectos secundarios y formas de administración adecuadas corroboran el hecho de que existen algunas controversias en cuanto al uso de corticoides, como la hidrocortisona, para el tratamiento de pacientes con sepsis, incluso con resultados satisfactorios. Consideraciones finales: los corticosteroides, especialmente la hidrocortisona, pueden usarse para tratar pacientes con sepsis. De acuerdo con la literatura utilizada, los resultados son satisfactorios y el costeo es fácil de cumplir. Sin embargo, el uso de estos fármacos, aun con beneficios, sigue siendo controvertido, debido a los efectos secundarios que provocan, la posología y la forma de administración. Por lo tanto, existen discusiones sobre este tema.Introdução: a sepse consiste em uma doença inflamatória sistêmica associada a uma infecção com manifestações graves que ocorre por todo o organismo. No entanto, essa infecção não precisa estar necessariamente em todos os locais do organismo, pode estar restrita em apenas um local, mas causar uma resposta inflamatória por todo o corpo para tentar controlar a causa da infecção. Objetivo: demonstrar as atuais evidências sobre o uso de corticosteroides no tratamento da sepse em paciente hospitalizados nas unidades de terapia intensiva (UTI’s). Metodologia: trata-se de uma pesquisa descritiva do tipo revisão integrativa da literatura. Foi realizado o cruzamento dos descritores, em inglês: "sepsis", "hemodynamic", "corticosteroids" em português: "sepse", "hemodinâmica", "corticosteroides" e em espanhol: "sepsis", "hemodinámico", "corticosteroides", nas seguintes bases de dados: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Biblioteca Virtual em Saúde (BVS) e EBSCO Information Services. Resultados e discussão: o tratamento pode ser feito com corticosteroides a fim de atenuar e modificar a resposta inflamatória, além de oferecerem um custo acessível. Porém, alguns efeitos colaterais e as formas adequadas de administração corroboram para que haja algumas controvérsias quanto ao uso dos corticoides, como a hidrocortisona, para tratamento de pacientes com sepse, mesmo com resultados satisfatórios. Considerações finais: os corticoides, em especial a hidrocortisona, podem ser utilizados para o tratamento dos pacientes com sepse. Conforme as literaturas utilizadas, os resultados são satisfatórios e possuem um custeio de fácil adesão. Contudo, o uso destes medicamentos, mesmo apresentando benefícios, ainda é controverso, devido aos efeitos colaterais causados, à posologia e à forma de administração. Desta forma, discussões acerca deste assunto existem.Research, Society and Development2022-02-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2619610.33448/rsd-v11i2.26196Research, Society and Development; Vol. 11 No. 2; e59211226196Research, Society and Development; Vol. 11 Núm. 2; e59211226196Research, Society and Development; v. 11 n. 2; e592112261962525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/26196/22891Copyright (c) 2022 Melina Fonseca Maia França Coury Alves; Bárbara Queiroz de Figueiredo; Bruno Faria Coury; Flávia Garcia Freitas; Julia da Cunha Ribeiro; Júlia de Sousa Oliveira; Júlia Silva Coimbra Costa; Juliana Silva Neiva; Rúbia Carla Oliveirahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessAlves, Melina Fonseca Maia França Coury Figueiredo, Bárbara Queiroz deCoury, Bruno FariaFreitas, Flávia GarciaRibeiro, Julia da CunhaOliveira, Júlia de SousaCosta, Júlia Silva CoimbraNeiva, Juliana SilvaOliveira, Rúbia Carla2022-02-07T01:42:50Zoai:ojs.pkp.sfu.ca:article/26196Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:44:17.826291Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
Evidencia sobre el uso de glucocorticoides como terapia para la sepsis: una revisión integrativa de la literatura
Evidências acerca do uso de glicocorticoides como terapêutica para sepse: uma revisão integrativa de literatura
title Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
spellingShingle Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
Alves, Melina Fonseca Maia França Coury
Glucocorticoides
Septicemia
Terapia intensiva.
Glucocorticoids
Sepsis
Intensive therapy.
Glicocorticoides
Sepse
Terapia intensiva.
title_short Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
title_full Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
title_fullStr Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
title_full_unstemmed Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
title_sort Evidence about the use of glucocorticoids as therapy for sepsis: an integrative literature review
author Alves, Melina Fonseca Maia França Coury
author_facet Alves, Melina Fonseca Maia França Coury
Figueiredo, Bárbara Queiroz de
Coury, Bruno Faria
Freitas, Flávia Garcia
Ribeiro, Julia da Cunha
Oliveira, Júlia de Sousa
Costa, Júlia Silva Coimbra
Neiva, Juliana Silva
Oliveira, Rúbia Carla
author_role author
author2 Figueiredo, Bárbara Queiroz de
Coury, Bruno Faria
Freitas, Flávia Garcia
Ribeiro, Julia da Cunha
Oliveira, Júlia de Sousa
Costa, Júlia Silva Coimbra
Neiva, Juliana Silva
Oliveira, Rúbia Carla
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Alves, Melina Fonseca Maia França Coury
Figueiredo, Bárbara Queiroz de
Coury, Bruno Faria
Freitas, Flávia Garcia
Ribeiro, Julia da Cunha
Oliveira, Júlia de Sousa
Costa, Júlia Silva Coimbra
Neiva, Juliana Silva
Oliveira, Rúbia Carla
dc.subject.por.fl_str_mv Glucocorticoides
Septicemia
Terapia intensiva.
Glucocorticoids
Sepsis
Intensive therapy.
Glicocorticoides
Sepse
Terapia intensiva.
topic Glucocorticoides
Septicemia
Terapia intensiva.
Glucocorticoids
Sepsis
Intensive therapy.
Glicocorticoides
Sepse
Terapia intensiva.
description Introduction: sepsis is a systemic inflammatory disease associated with an infection with severe manifestations that occurs throughout the body. However, this infection does not necessarily have to be everywhere in the body, it can be restricted to just one place, but cause an inflammatory response throughout the body to try to control the cause of the infection. Objective: to demonstrate the current evidence on the use of corticosteroids in the treatment of sepsis in patients hospitalized in intensive care units (ICUs). Methodology: this is a descriptive research of the integrative literature review type. The descriptors were crossed, in English: "sepsis", "hemodynamic", "corticosteroids" in Portuguese: "sepsis", "hemodynamics", "corticosteroids" and in Spanish: "sepsis", "hemodynamic", "corticosteroids", in the following databases: National Library of Medicine (PubMed MEDLINE), Scientific Electronic Library Online (Scielo), Cochrane Database of Systematic Reviews (CDSR), Google Scholar, Virtual Health Library (BVS) and EBSCO Information Services. Results and discussion: treatment can be done with corticosteroids in order to attenuate and modify the inflammatory response, in addition to offering an affordable cost. However, some side effects and adequate forms of administration corroborate the fact that there are some controversies regarding the use of corticosteroids, such as hydrocortisone, for the treatment of patients with sepsis, even with satisfactory results. Final considerations: corticosteroids, especially hydrocortisone, can be used to treat patients with sepsis. According to the literature used, the results are satisfactory and costing is easy to adhere to. However, the use of these drugs, even with benefits, is still controversial, due to the side effects caused, the dosage and the form of administration. Thus, discussions on this subject exist.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-06
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/26196
10.33448/rsd-v11i2.26196
url https://rsdjournal.org/index.php/rsd/article/view/26196
identifier_str_mv 10.33448/rsd-v11i2.26196
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/26196/22891
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 2; e59211226196
Research, Society and Development; Vol. 11 Núm. 2; e59211226196
Research, Society and Development; v. 11 n. 2; e59211226196
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052762692780032